Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -68.75% is 47% below its 5-year average of -46.76%, near the low end of its 5-year range (-68.75%–-26.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.71% below its 12-month average of -55.58%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -18.16%.
RETURN ON ASSETS (ROA)
-68.75%
RETURN ON ASSETS (ROA) AVG TTM
-55.58%
RETURN ON ASSETS (ROA) AVG 3Y
-51.15%
RETURN ON ASSETS (ROA) AVG 5Y
-46.76%
RETURN ON ASSETS (ROA) AVG 10Y
-203.19%
RETURN ON ASSETS (ROA) AVG 15Y
-98.38%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-23.71%
CURRENT VS 3Y AVG
-34.42%
CURRENT VS 5Y AVG
-47.02%
CURRENT VS 10Y AVG
+66.17%
CURRENT VS 15Y AVG
+30.12%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.75%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-116.54%
vs the sector median at left
Rezolute, Inc.
Market Cap
$411.65M
Return on Assets (ROA)
-68.75%
TTM Avg
-55.58%
3Y Avg
-51.15%
5Y Avg
-46.76%
Market Cap
$411.76M
Return on Assets (ROA)
-14.54%
TTM Avg
-48.52%
3Y Avg
-33.40%
5Y Avg
-26.00%
Market Cap
$410.19M
Return on Assets (ROA)
12.09%
TTM Avg
1.03%
3Y Avg
-6.34%
5Y Avg
-7.45%
Market Cap
$409.99M
Return on Assets (ROA)
-23.05%
TTM Avg
-30.00%
3Y Avg
-27.77%
5Y Avg
-27.77%
Market Cap
$407.34M
Return on Assets (ROA)
-71.16%
TTM Avg
-43.23%
3Y Avg
-31.68%
5Y Avg
-18.72%
Market Cap
$403.87M
Return on Assets (ROA)
-41.33%
TTM Avg
-54.52%
3Y Avg
-54.52%
5Y Avg
-54.52%
Market Cap
$416.66M
Return on Assets (ROA)
-17.62%
TTM Avg
-32.09%
3Y Avg
-24.12%
5Y Avg
-19.05%
Market Cap
$406.04M
Return on Assets (ROA)
-45.47%
TTM Avg
-26.84%
3Y Avg
-30.13%
5Y Avg
-31.02%
Market Cap
$406.41M
Return on Assets (ROA)
-30.75%
TTM Avg
-34.79%
3Y Avg
-68.11%
5Y Avg
-68.11%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $411.65M | -68.75% | -55.58% | -51.15% | -46.76% |
| Prothena Corporation plc (PRTA)vs › | $411.76M | -14.54% | -48.52% | -33.40% | -26.00% |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.19M | 12.09% | 1.03% | -6.34% | -7.45% |
| Shoulder Innovations, Inc. (SI)vs › | $409.99M | -23.05% | -30.00% | -27.77% | -27.77% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $407.34M | -71.16% | -43.23% | -31.68% | -18.72% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $403.87M | -41.33% | -54.52% | -54.52% | -54.52% |
| Myriad Genetics, Inc. (MYGN)vs › | $416.66M | -17.62% | -32.09% | -24.12% | -19.05% |
| Neurogene Inc. (NGNE)vs › | $406.04M | -45.47% | -26.84% | -30.13% | -31.02% |
| Carlsmed, Inc. (CARL)vs › | $406.41M | -30.75% | -34.79% | -68.11% | -68.11% |
| Senseonics Holdings, Inc. (SENS)vs › | $419.42M | -61.86% | -66.50% | -24.17% | -122.74% |
ROA
-68.8%
ROE
-77.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -68.75% |
| 2025-06-30 | -42.40% |
| 2024-06-30 | -51.57% |
| 2023-06-30 | -41.86% |
| 2022-06-30 | -26.94% |
| 2021-06-30 | -49.06% |
| 2020-06-30 | -185.44% |
| 2019-06-30 | -248.26% |
| 2018-06-30 | -1193.10% |
| 2017-06-30 | -190.77% |
| 2016-06-30 | -136.98% |
| 2015-06-30 | -100.88% |
| 2014-06-30 | -131.41% |
| 2013-06-30 | -609.39% |
| 2012-06-30 | -4.61% |
